SOURCE: Greenhouse Solutions Inc.

February 25, 2015 08:30 ET

Greenhouse Solutions Inc. Announces First Product in Their New Healthcare Line for Pain in Companion Animals

GREENWOOD VILLAGE, CO--(Marketwired - February 25, 2015) - Greenhouse Solutions Inc. (OTC PINK: GRSU) today announced their plans to manufacture, market and sell a proprietary product for the alleviation of pain in companion animals utilizing Cannabidiols (CBDs) and Probiotics. Greenhouse Solutions previously announced that they were creating products for both the personal health and companion pet markets utilizing a licensed probiotic delivery system (US Patent #6,080,401). Today's announcement marks the first product to be developed in the Company's new division that takes advantage of new research in CBD.

"I have been working with Dr. Reddy to formulate products that utilize the best aspects of the new research and licensed technologies," commented Rik J Deitsch, CEO of Greenhouse Solutions. "I'm very excited to get this first product underway as we create new paradigms with the use of Cannabidiols and probiotics for the wellness marketplace," he continued. "We know that the pain market in companion animals is large and mostly unmet. This will be a necessary product that will make a real difference for millions of pets," he concluded.

According to The American Pet Products Association (APPA) there are 83 million dogs and 95 million cats in the US. These companion animals are as susceptible as humans to ailments that require pain-relieving solutions. The total market for companion animals in the US reached an estimated $58.5 billion in 2014. Of these expenditures, over $13 billion was spent on medication for the animals. Additionally, a 2009 survey conducted by Virbac Pharmaceuticals puts the annual US market for companion animal pain relievers at more than $250 million.

"Unlike the pain in the human beings, which he or she can communicate to get medication, the animals specifically , companion animals (dogs and cats) suffer thru the pain," Stated Dr. M.S Reddy. "Only person that can perceive the pain of the pet is the pet owner. Due to severe pain, the dogs and cats do not eat properly , do not rest and thus develop other serious complications such as, constipation, pruritis (severe itching of the anal area) and restlessness etc. etc," he continued. "This all natural patented approach of Green House Solutions using Cannabidiols (CBDs) and species specific Probiotics will alleviate the pain thru the synbiosis. In this particular preparation, Probiotics not only help the activation of the Cannabidiols to enhance the pain relieving property (even at a small dose) but also improve the overall Gastro Intestinal Health of the animals. These all natural products of Green House Solutions does not give any serious side effects (unlike the other Allopathic medicines), which will hurt the health of the companion animals," he concluded.

Greenhouse Solutions expects the product to be finalized and sent to manufacturing within the first quarter with an expected launch in the second quarter of this year.

About Greenhouse Solutions, Inc.
Greenhouse Solutions operates three distinct business units within the burgeoning cannabis market: Greenhouse Solutions' Design & Consulting Service offers an all-inclusive solution to the expansion and efficiency of hydroponic and agricultural businesses nationwide. The Company is able to supply a comprehensive solution to the design, build, implementation, production, and expansion of all variations of indoor, outdoor and greenhouse agricultural business; Greenhouse Solutions' Product Development develops, markets, produces and sells cannabidiol ("CBD") products for both the personal health and companion pet markets utilizing a licensed probiotic delivery system (US Patent #6,080,401) and other licensed formulas. Cannabidiol (CBD) is a naturally-occurring substance found in both the cannabis and hemp species of the Cannabis Sativa plant; and Growhouse Solutions acts as a distributor for a variety of equipment, supplies and nutrients for the growhouse industry.

We encourage all current and prospective shareholders to visit our website at:

SEC Disclaimer
This press release contains forward-looking statements. The words or phrases "would be," "will allow," "intends to," "will likely result," "are expected to," "will continue," "is anticipated," "estimate," "project," or similar expressions are intended to identify "forward-looking statements." Actual results could differ materially from those projected in Greenhouse Solutions' ("the Company's") business plan. The production of the new product for pet pain should not be construed as an indication in any way whatsoever of the future value of the Company's common stock or its present or future financial condition. The Company's filings may be accessed at the SEC's Edgar system at Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company cautions readers not to place reliance on such statements. Unless otherwise required by applicable law, we do not undertake, and we specifically disclaim any obligation, to update any forward-looking statements to reflect occurrences, developments, unanticipated events or circumstances after the date of such statement.

Contact Information